{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T15:09:08Z","timestamp":1786806548381,"version":"build-2736575974"},"reference-count":175,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,4,10]]},"DOI":"10.7759\/cureus.82041","type":"journal-article","created":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T00:45:11Z","timestamp":1744332311000},"source":"Crossref","is-referenced-by-count":5,"title":["Cardiovascular Sequelae of the COVID-19 Vaccines"],"prefix":"10.7759","author":[{"given":"James N","family":"Nitz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kylie K","family":"Ruprecht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukas J","family":"Henjum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew Y","family":"Matta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barnabas T","family":"Shiferaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoie L","family":"Weber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jalon M","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raven","family":"May","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen J","family":"Baio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth J","family":"Fiala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alaa A","family":"Abd-Elsayed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"Emergency use authorization for vaccines to prevent COVID-19; guidance for industry. (2022). Accessed. August 23, 2023: https:\/\/www.fda.gov\/emergency-preparedness-and-response\/mcm-legal-regulatory-and-policy-framework\/emergency-use-autho...."},{"key":"ref2","unstructured":"Holder J. Tracking coronavirus vaccinations around the world. (2021). Accessed: August 11, 2023: https:\/\/www.nytimes.com\/interactive\/2021\/world\/covid-vaccinations-tracker.html."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.121.056135","article-title":"Myocarditis with COVID-19 mRNA vaccines","volume":"144","author":"Bozkurt B","year":"2021","unstructured":"Bozkurt B, Kamat I, Hotez PJ. Myocarditis with COVID-19 mRNA vaccines. Circulation. 2021, 144:471-84. 10.1161\/CIRCULATIONAHA.121.056135","journal-title":"Circulation"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1002\/rmv.2318","article-title":"Cardiac complications following mRNA COVID-19 vaccines: A systematic review of case reports and case series","volume":"32","author":"Fazlollahi A","year":"2022","unstructured":"Fazlollahi A, Zahmatyar M, Noori M, et al.. Cardiac complications following mRNA COVID-19 vaccines: A systematic review of case reports and case series. Rev Med Virol. 2022, 32:e2318. 10.1002\/rmv.2318","journal-title":"Rev Med Virol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.2669","article-title":"Myocarditis following COVID-19 vaccine: Incidence, presentation, diagnosis, pathophysiology, therapy, and outcomes put into perspective. A clinical consensus document supported by the Heart Failure Association of the European Society of Cardiology (ESC) and the ESC Working Group on Myocardial and Pericardial Diseases","volume":"24","author":"Heidecker B","year":"2022","unstructured":"Heidecker B, Dagan N, Balicer R, et al.. Myocarditis following COVID-19 vaccine: Incidence, presentation, diagnosis, pathophysiology, therapy, and outcomes put into perspective. A clinical consensus document supported by the Heart Failure Association of the European Society of Cardiology (ESC) and the ESC Working Group on Myocardial and Pericardial Diseases. Eur J Heart Fail. 2022, 24:2000-18. 10.1002\/ejhf.2669","journal-title":"Eur J Heart Fail"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2110475","article-title":"Safety of the BNT162b2 mRNA Covid-19 Vaccine in a nationwide setting","volume":"385","author":"Barda N","year":"2021","unstructured":"Barda N, Dagan N, Ben-Shlomo Y, et al.. Safety of the BNT162b2 mRNA Covid-19 Vaccine in a nationwide setting. N Engl J Med. 2021, 385:1078-90. 10.1056\/NEJMoa2110475","journal-title":"N Engl J Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000001064","article-title":"SARS-CoV-2 infection and associated cardiovascular manifestations and complications in children and young adults: A scientific statement from the American Heart Association","volume":"145","author":"Jone PN","year":"2022","unstructured":"Jone PN, John A, Oster ME, et al.. SARS-CoV-2 infection and associated cardiovascular manifestations and complications in children and young adults: A scientific statement from the American Heart Association. Circulation. 2022, 145:e1037-52. 10.1161\/CIR.0000000000001064","journal-title":"Circulation"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines10050700","article-title":"Cardiac adverse events after vaccination-A systematic review","volume":"10","author":"Parmar K","year":"2022","unstructured":"Parmar K, Subramanyam S, Del Rio-Pertuz G, Sethi P, Argueta-Sosa E. Cardiac adverse events after vaccination-A systematic review. Vaccines. 2022, 10:700. 10.3390\/vaccines10050700","journal-title":"Vaccines"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s00392-022-02070-7","article-title":"COVID-19 vaccination and carditis in children and adolescents: A systematic review and meta-analysis","volume":"111","author":"Chou OH","year":"2022","unstructured":"Chou OH, Mui J, Chung CT, et al.. COVID-19 vaccination and carditis in children and adolescents: A systematic review and meta-analysis. Clin Res Cardiol. 2022, 111:1161-73. 10.1007\/s00392-022-02070-7","journal-title":"Clin Res Cardiol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/hcab252","article-title":"Acute myocardial infarction and myocarditis following COVID-19 vaccination","volume":"116","author":"Aye YN","year":"2023","unstructured":"Aye YN, Mai AS, Zhang A, et al.. Acute myocardial infarction and myocarditis following COVID-19 vaccination. QJM. 2023, 116:279-83. 10.1093\/qjmed\/hcab252","journal-title":"QJM"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2021.07.009","article-title":"COVID-19 vaccine and myocarditis","volume":"157","author":"Salah HM","year":"2021","unstructured":"Salah HM, Mehta JL. COVID-19 vaccine and myocarditis. Am J Cardiol. 2021, 157:146-8. 10.1016\/j.amjcard.2021.07.009","journal-title":"Am J Cardiol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.4330\/wjc.v14.i7.382","article-title":"COVID-19 vaccine-associated myocarditis","volume":"14","author":"Morgan MC","year":"2022","unstructured":"Morgan MC, Atri L, Harrell S, Al-Jaroudi W, Berman A. COVID-19 vaccine-associated myocarditis. World J Cardiol. 2022, 14:382-91. 10.4330\/wjc.v14.i7.382","journal-title":"World J Cardiol"},{"key":"ref13","article-title":"Myocarditis following COVID-19 vaccination: A systematic review of case reports","volume":"95","author":"Behers BJ","year":"2022","unstructured":"Behers BJ, Patrick GA, Jones JM, et al.. Myocarditis following COVID-19 vaccination: A systematic review of case reports. Yale J Biol Med. 2022, 95:237-47.","journal-title":"Yale J Biol Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.4414\/smw.2021.w30087","article-title":"The very low risk of myocarditis and pericarditis after mRNA COVID-19 vaccination should not discourage vaccination","volume":"151","author":"Haaf P","year":"2021","unstructured":"Haaf P, Kuster GM, Mueller C, et al.. The very low risk of myocarditis and pericarditis after mRNA COVID-19 vaccination should not discourage vaccination. Swiss Med Wkly. 2021, 151:w30087. 10.4414\/smw.2021.w30087","journal-title":"Swiss Med Wkly"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccl.2022.05.002","article-title":"Myocarditis following COVID-19 vaccination","volume":"40","author":"Marschner CA","year":"2022","unstructured":"Marschner CA, Shaw KE, Tijmes FS, et al.. Myocarditis following COVID-19 vaccination. Cardiol Clin. 2022, 40:375-88. 10.1016\/j.ccl.2022.05.002","journal-title":"Cardiol Clin"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1007\/s40119-021-00248-0","article-title":"Cardiovascular complications of SARS-CoV-2 vaccines: An overview","volume":"11","author":"Shiravi AA","year":"2022","unstructured":"Shiravi AA, Ardekani A, Sheikhbahaei E, Heshmat-Ghahdarijani K. Cardiovascular complications of SARS-CoV-2 vaccines: An overview. Cardiol Ther. 2022, 11:13-21. 10.1007\/s40119-021-00248-0","journal-title":"Cardiol Ther"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2022.0583","article-title":"SARS-CoV-2 vaccination and myocarditis in a Nordic cohort study of 23 million residents","volume":"7","author":"Karlstad \u00d8","year":"2022","unstructured":"Karlstad \u00d8, Hovi P, Husby A, et al.. SARS-CoV-2 vaccination and myocarditis in a Nordic cohort study of 23 million residents. JAMA Cardiol. 2022, 7:600-12. 10.1001\/jamacardio.2022.0583","journal-title":"JAMA Cardiol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.dsx.2021.102205","article-title":"COVID-19 vaccine-induced myocarditis: Case report with literature review","volume":"15","author":"Nassar M","year":"2021","unstructured":"Nassar M, Nso N, Gonzalez C, et al.. COVID-19 vaccine-induced myocarditis: Case report with literature review. Diabetes Metab Syndr. 2021, 15:102205. 10.1016\/j.dsx.2021.102205","journal-title":"Diabetes Metab Syndr"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.17137","article-title":"Cardiovascular and haematological events post COVID-19 vaccination: A systematic review","volume":"26","author":"Al-Ali D","year":"2022","unstructured":"Al-Ali D, Elshafeey A, Mushannen M, et al.. Cardiovascular and haematological events post COVID-19 vaccination: A systematic review. J Cell Mol Med. 2022, 26:636-53. 10.1111\/jcmm.17137","journal-title":"J Cell Mol Med"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/2438913","article-title":"Unraveling the mystery of COVID-19 postvaccination myocarditis: A systematic review of current cases","volume":"2022","author":"Ghoshouni H","year":"2022","unstructured":"Ghoshouni H, Bagherieh S, Parvizinia M, Askari M, Sadeghi M, Mirmosayyeb O. Unraveling the mystery of COVID-19 postvaccination myocarditis: A systematic review of current cases. Int J Clin Pract. 2022, 2022:2438913. 10.1155\/2022\/2438913","journal-title":"Int J Clin Pract"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1186\/s43044-022-00260-2","article-title":"COVID-19 and myocarditis: A review of literature","volume":"74","author":"Ali M","year":"2022","unstructured":"Ali M, Shiwani HA, Elfaki MY, et al.. COVID-19 and myocarditis: A review of literature. Egypt Heart J. 2022, 74:23. 10.1186\/s43044-022-00260-2","journal-title":"Egypt Heart J"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2021.08.001","article-title":"A comprehensive analysis of the efficacy and safety of COVID-19 vaccines","volume":"29","author":"Cai C","year":"2021","unstructured":"Cai C, Peng Y, Shen E, et al.. A comprehensive analysis of the efficacy and safety of COVID-19 vaccines. Mol Ther. 2021, 29:2794-805. 10.1016\/j.ymthe.2021.08.001","journal-title":"Mol Ther"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1007\/s11886-022-01801-6","article-title":"COVID-19 vaccine-related myocardial and pericardial inflammation","volume":"24","author":"Furqan M","year":"2022","unstructured":"Furqan M, Chawla S, Majid M, Mazumdar S, Mahalwar G, Harmon E, Klein A. COVID-19 vaccine-related myocardial and pericardial inflammation. Curr Cardiol Rep. 2022, 24:2031-41. 10.1007\/s11886-022-01801-6","journal-title":"Curr Cardiol Rep"},{"key":"ref24","article-title":"Case report of COVID-19 mRNA vaccine-associated myocarditis","volume":"121","author":"Licata T","year":"2022","unstructured":"Licata T, Clements A. Case report of COVID-19 mRNA vaccine-associated myocarditis. WMJ. 2022, 121:50-2.","journal-title":"WMJ"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.dsx.2022.102513","article-title":"Global reports of myocarditis following COVID-19 vaccination: A systematic review and meta-analysis","volume":"16","author":"Ahmed SK","year":"2022","unstructured":"Ahmed SK, Mohamed MG, Essa RA, Ahmed Rashad EA, Ibrahim PK, Khdir AA, Wsu ZH. Global reports of myocarditis following COVID-19 vaccination: A systematic review and meta-analysis. Diabetes Metab Syndr. 2022, 16:102513. 10.1016\/j.dsx.2022.102513","journal-title":"Diabetes Metab Syndr"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.27883","article-title":"Catecholamines are the key trigger of COVID-19 mRNA vaccine-induced myocarditis: A compelling hypothesis supported by epidemiological, anatomopathological, molecular, and physiological findings","volume":"14","author":"Cadegiani FA","year":"2022","unstructured":"Cadegiani FA. Catecholamines are the key trigger of COVID-19 mRNA vaccine-induced myocarditis: A compelling hypothesis supported by epidemiological, anatomopathological, molecular, and physiological findings. Cureus. 2022, 14:e27883. 10.7759\/cureus.27883","journal-title":"Cureus"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.21542\/gcsp.2021.18","article-title":"Myocarditis and pericarditis in association with COVID-19 mRNA-vaccination: Cases from a regional pharmacovigilance centre","volume":"2021","author":"Istampoulouoglou I","year":"2021","unstructured":"Istampoulouoglou I, Dimitriou G, Sp\u00e4ni S, et al.. Myocarditis and pericarditis in association with COVID-19 mRNA-vaccination: Cases from a regional pharmacovigilance centre. Glob Cardiol Sci Pract. 2021, 2021:e202118. 10.21542\/gcsp.2021.18","journal-title":"Glob Cardiol Sci Pract"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/j.hlc.2022.02.002","article-title":"Myocarditis following COVID-19 vaccination: A systematic review (October 2020-October 2021)","volume":"31","author":"Lee AS","year":"2022","unstructured":"Lee AS, Balakrishnan ID, Khoo CY, et al.. Myocarditis following COVID-19 vaccination: A systematic review (October 2020-October 2021). Heart Lung Circ. 2022, 31:757-65. 10.1016\/j.hlc.2022.02.002","journal-title":"Heart Lung Circ"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/j.pcad.2022.10.004","article-title":"Myocarditis associated with COVID-19 and its vaccines - a systematic review","volume":"74","author":"Rout A","year":"2022","unstructured":"Rout A, Suri S, Vorla M, Kalra DK. Myocarditis associated with COVID-19 and its vaccines - a systematic review. Prog Cardiovasc Dis. 2022, 74:111-21. 10.1016\/j.pcad.2022.10.004","journal-title":"Prog Cardiovasc Dis"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2022.02.017","article-title":"Myocarditis following mRNA Covid-19 vaccination: A pooled analysis","volume":"40","author":"Bellos I","year":"2022","unstructured":"Bellos I, Karageorgiou V, Viskin D. Myocarditis following mRNA Covid-19 vaccination: A pooled analysis. Vaccine. 2022, 40:1768-74. 10.1016\/j.vaccine.2022.02.017","journal-title":"Vaccine"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines11020362","article-title":"Comparison of COVID-19 vaccine-associated myocarditis and viral myocarditis pathology","volume":"11","author":"Hamedi KR","year":"2023","unstructured":"Hamedi KR, Loftus G, Traylor L, Goodwin R, Arce S. Comparison of COVID-19 vaccine-associated myocarditis and viral myocarditis pathology. Vaccines. 2023, 11:362. 10.3390\/vaccines11020362","journal-title":"Vaccines"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2022.08.026","article-title":"Clinical cardiovascular emergencies and the cellular basis of COVID-19 vaccination: From dream to reality?","volume":"124","author":"Li YE","year":"2022","unstructured":"Li YE, Wang S, Reiter RJ, Ren J. Clinical cardiovascular emergencies and the cellular basis of COVID-19 vaccination: From dream to reality?. Int J Infect Dis. 2022, 124:1-10. 10.1016\/j.ijid.2022.08.026","journal-title":"Int J Infect Dis"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.915580","article-title":"Myocarditis following COVID-19 vaccine use: Can it play a role for conditioning immunization schedules?","volume":"13","author":"Esposito S","year":"2022","unstructured":"Esposito S, Caminiti C, Giordano R, Argentiero A, Ramundo G, Principi N. Myocarditis following COVID-19 vaccine use: Can it play a role for conditioning immunization schedules?. Front Immunol. 2022, 13:915580. 10.3389\/fimmu.2022.915580","journal-title":"Front Immunol"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1007\/s00246-022-02851-x","article-title":"Cardiac complications associated with COVID-19, MIS-C, and mRNA COVID-19 vaccination","volume":"43","author":"Chin SE","year":"2022","unstructured":"Chin SE, Bhavsar SM, Corson A, Ghersin ZJ, Kim HS. Cardiac complications associated with COVID-19, MIS-C, and mRNA COVID-19 vaccination. Pediatr Cardiol. 2022, 43:483-8. 10.1007\/s00246-022-02851-x","journal-title":"Pediatr Cardiol"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.3390\/children8070607","article-title":"Myocarditis and pericarditis following mRNA COVID-19 vaccination: What do we know so far?","volume":"8","author":"Das BB","year":"2021","unstructured":"Das BB, Moskowitz WB, Taylor MB, Palmer A. Myocarditis and pericarditis following mRNA COVID-19 vaccination: What do we know so far?. Children (Basel). 2021, 8:607. 10.3390\/children8070607","journal-title":"Children (Basel)"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1007\/s10741-022-10243-9","article-title":"Myocarditis following COVID-19 vaccination in adolescents and adults: A cumulative experience of 2021","volume":"27","author":"Ilonze OJ","year":"2022","unstructured":"Ilonze OJ, Guglin ME. Myocarditis following COVID-19 vaccination in adolescents and adults: A cumulative experience of 2021. Heart Fail Rev. 2022, 27:2033-43. 10.1007\/s10741-022-10243-9","journal-title":"Heart Fail Rev"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1016\/j.amsu.2022.103486","article-title":"Development of myocarditis and pericarditis after COVID-19 vaccination in adult population: A systematic review","volume":"76","author":"Fatima M","year":"2022","unstructured":"Fatima M, Ahmad Cheema H, Ahmed Khan MH, et al.. Development of myocarditis and pericarditis after COVID-19 vaccination in adult population: A systematic review. Ann Med Surg (Lond). 2022, 76:103486. 10.1016\/j.amsu.2022.103486","journal-title":"Ann Med Surg (Lond)"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.3390\/v13122493","article-title":"Cardiomyopathy associated with anti-SARS-CoV-2 vaccination: What do we know?","volume":"13","author":"Parra-Lucares A","year":"2021","unstructured":"Parra-Lucares A, Toro L, Weitz-Mu\u00f1oz S, Ramos C. Cardiomyopathy associated with anti-SARS-CoV-2 vaccination: What do we know?. Viruses. 2021, 13:2493. 10.3390\/v13122493","journal-title":"Viruses"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.12997\/jla.2023.12.2.119","article-title":"Benefits and harms of COVID-19 vaccines in cardiovascular disease: A comprehensive review","volume":"12","author":"Chen CY","year":"2023","unstructured":"Chen CY, Su TC. Benefits and harms of COVID-19 vaccines in cardiovascular disease: A comprehensive review. J Lipid Atheroscler. 2023, 12:119-31. 10.12997\/jla.2023.12.2.119","journal-title":"J Lipid Atheroscler"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2022.951314","article-title":"Myocarditis in SARS-CoV-2 infection vs. COVID-19 vaccination: A systematic review and meta-analysis","volume":"9","author":"Voleti N","year":"2022","unstructured":"Voleti N, Reddy SP, Ssentongo P. Myocarditis in SARS-CoV-2 infection vs. COVID-19 vaccination: A systematic review and meta-analysis. Front Cardiovasc Med. 2022, 9:951314. 10.3389\/fcvm.2022.951314","journal-title":"Front Cardiovasc Med"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines9101102","article-title":"Safety, immunogenicity, and efficacy of COVID-19 vaccines in children and adolescents: A systematic review","volume":"9","author":"Lv M","year":"2021","unstructured":"Lv M, Luo X, Shen Q, et al.. Safety, immunogenicity, and efficacy of COVID-19 vaccines in children and adolescents: A systematic review. Vaccines (Basel). 2021, 9:1102. 10.3390\/vaccines9101102","journal-title":"Vaccines (Basel)"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1007\/s40267-022-00956-0","article-title":"mRNA COVID-19 vaccines are well tolerated and myopericarditis is a rare adverse event following immunisation","volume":"38","author":"Fenton C","year":"2022","unstructured":"Fenton C, Lee A. mRNA COVID-19 vaccines are well tolerated and myopericarditis is a rare adverse event following immunisation. Drugs Ther Perspect. 2022, 38:532-40. 10.1007\/s40267-022-00956-0","journal-title":"Drugs Ther Perspect"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2022.105196","article-title":"Immunologic response, efficacy, and safety of vaccines against COVID-19 infection in healthy and immunosuppressed children and adolescents aged 2 - 21 years old: A systematic review and meta-analysis","volume":"153","author":"Sadeghi S","year":"2022","unstructured":"Sadeghi S, Kalantari Y, Shokri S, Fallahpour M, Nafissi N, Goodarzi A, Valizadeh R. Immunologic response, efficacy, and safety of vaccines against COVID-19 infection in healthy and immunosuppressed children and adolescents aged 2 - 21 years old: A systematic review and meta-analysis. J Clin Virol. 2022, 153:105196. 10.1016\/j.jcv.2022.105196","journal-title":"J Clin Virol"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11154521","article-title":"Clinical characteristics of patients with myocarditis following COVID-19 mRNA vaccination: A systematic review and meta-analysis","volume":"11","author":"Matar RH","year":"2022","unstructured":"Matar RH, Mansour R, Nakanishi H, et al.. Clinical characteristics of patients with myocarditis following COVID-19 mRNA vaccination: A systematic review and meta-analysis. J Clin Med. 2022, 11:4521. 10.3390\/jcm11154521","journal-title":"J Clin Med"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2022-060295","article-title":"COVID-19 vaccine safety first year findings in adolescents","volume":"151","author":"Hesse EM","year":"2023","unstructured":"Hesse EM, Hause A, Myers T, et al.. COVID-19 vaccine safety first year findings in adolescents. Pediatrics. 2023, 151:e2022060295. 10.1542\/peds.2022-060295","journal-title":"Pediatrics"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2021.12.007","article-title":"Meta-analysis of risk of myocarditis after messenger RNA COVID-19 vaccine","volume":"167","author":"Wang M","year":"2022","unstructured":"Wang M, Wen W, Zhou M, Wang C, Feng ZH. Meta-analysis of risk of myocarditis after messenger RNA COVID-19 vaccine. Am J Cardiol. 2022, 167:155-7. 10.1016\/j.amjcard.2021.12.007","journal-title":"Am J Cardiol"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1016\/j.prrv.2022.03.002","article-title":"Covid-19 in children aged 5-11: Examining the issues surrounding vaccination and public health policy","volume":"43","author":"Myers V","year":"2022","unstructured":"Myers V, Saban M, Wilf-Miron R. Covid-19 in children aged 5-11: Examining the issues surrounding vaccination and public health policy. Paediatr Respir Rev. 2022, 43:85-90. 10.1016\/j.prrv.2022.03.002","journal-title":"Paediatr Respir Rev"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1007\/s13337-022-00755-1","article-title":"A comprehensive review on COVID-19 vaccines: Development, effectiveness, adverse effects, distribution and challenges","volume":"33","author":"Rahman MM","year":"2022","unstructured":"Rahman MM, Masum MH, Wajed S, Talukder A. A comprehensive review on COVID-19 vaccines: Development, effectiveness, adverse effects, distribution and challenges. Virusdisease. 2022, 33:1-22. 10.1007\/s13337-022-00755-1","journal-title":"Virusdisease"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.17305\/bb.2022.8779","article-title":"Myocarditis and coronavirus disease 2019 vaccination: A systematic review and meta-summary of cases","volume":"23","author":"Saputra PB","year":"2023","unstructured":"Saputra PB, Kurniawan RB, Trilistyoati D, et al.. Myocarditis and coronavirus disease 2019 vaccination: A systematic review and meta-summary of cases. Biomol Biomed. 2023, 23:546-67. 10.17305\/bb.2022.8779","journal-title":"Biomol Biomed"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1016\/j.hlc.2022.03.003","article-title":"Myocarditis and cardiac complications associated with COVID-19 and mRNA vaccination: A pragmatic narrative review to guide clinical practice","volume":"31","author":"Holland DJ","year":"2022","unstructured":"Holland DJ, Blazak PL, Martin J, Broom J, Poulter RS, Stanton T. Myocarditis and cardiac complications associated with COVID-19 and mRNA vaccination: A pragmatic narrative review to guide clinical practice. Heart Lung Circ. 2022, 31:924-33. 10.1016\/j.hlc.2022.03.003","journal-title":"Heart Lung Circ"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1002\/hsr2.740","article-title":"Clinical outcomes of Pfizer-BioNTech COVID-19 vaccine in children and adolescents: A systematic review","volume":"5","author":"Al-Qudimat AR","year":"2022","unstructured":"Al-Qudimat AR, Al-Zoubi RM, Elaarag M, et al.. Clinical outcomes of Pfizer-BioNTech COVID-19 vaccine in children and adolescents: A systematic review. Health Sci Rep. 2022, 5:e740. 10.1002\/hsr2.740","journal-title":"Health Sci Rep"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2022.01.037","article-title":"Myocarditis after RNA-based vaccines for coronavirus","volume":"353","author":"Cordero A","year":"2022","unstructured":"Cordero A, Cazorla D, Escribano D, Quintanilla MA, L\u00f3pez-Ayala JM, Berbel PP, Bertomeu-Gonz\u00e1lez V. Myocarditis after RNA-based vaccines for coronavirus. Int J Cardiol. 2022, 353:131-4. 10.1016\/j.ijcard.2022.01.037","journal-title":"Int J Cardiol"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.3390\/v15040929","article-title":"Diagnosis of acute myocarditis following mRNA vaccines against SARS-CoV-2: A methodological review","volume":"15","author":"Zuin M","year":"2023","unstructured":"Zuin M, Zimelli E, Dalla Valle C, Cavedon S, Rigatelli G, Bilato C. Diagnosis of acute myocarditis following mRNA vaccines against SARS-CoV-2: A methodological review. Viruses. 2023, 15:929. 10.3390\/v15040929","journal-title":"Viruses"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1111\/apa.16462","article-title":"COVID-19 review shows that benefits of vaccinating children and adolescents appear to outweigh risks of post-vaccination myopericarditis","volume":"111","author":"Morello R","year":"2022","unstructured":"Morello R, Pepe M, Martino L, Lazzareschi I, Chiaretti A, Gatto A, Curatola A. COVID-19 review shows that benefits of vaccinating children and adolescents appear to outweigh risks of post-vaccination myopericarditis. Acta Paediatr. 2022, 111:1846-52. 10.1111\/apa.16462","journal-title":"Acta Paediatr"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.26851","article-title":"A comprehensive analysis of myocarditis in formerly healthy individuals following SARS-CoV-2 vaccination (COVID-19 immunization)","volume":"14","author":"Sharma K","year":"2022","unstructured":"Sharma K, Patel S, Patel Z, et al.. A comprehensive analysis of myocarditis in formerly healthy individuals following SARS-CoV-2 vaccination (COVID-19 immunization). Cureus. 2022, 14:e26851. 10.7759\/cureus.26851","journal-title":"Cureus"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.112843","article-title":"Epidemiology, clinical ramifications, and cellular pathogenesis of COVID-19 mRNA-vaccination-induced adverse cardiovascular outcomes: A state-of-the-heart review","volume":"149","author":"Almas T","year":"2022","unstructured":"Almas T, Rehman S, Mansour E, et al.. Epidemiology, clinical ramifications, and cellular pathogenesis of COVID-19 mRNA-vaccination-induced adverse cardiovascular outcomes: A state-of-the-heart review. Biomed Pharmacother. 2022, 149:112843. 10.1016\/j.biopha.2022.112843","journal-title":"Biomed Pharmacother"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciac396","article-title":"Paving the way towards precision vaccinology: The paradigm of myocarditis after coronavirus disease 2019 (COVID-19) vaccination","volume":"75","author":"Lagousi T","year":"2022","unstructured":"Lagousi T, Papadatou I, Strempas P, Chatzikalil E, Spoulou V. Paving the way towards precision vaccinology: The paradigm of myocarditis after coronavirus disease 2019 (COVID-19) vaccination. Clin Infect Dis. 2022, 75:S18-23. 10.1093\/cid\/ciac396","journal-title":"Clin Infect Dis"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1186\/s42269-022-00955-1","article-title":"The role of miRNAs in viral myocarditis, and its possible implication in induction of mRNA-based COVID-19 vaccines-induced myocarditis","volume":"46","author":"AbdelMassih A","year":"2022","unstructured":"AbdelMassih A, Agha H, El-Saiedi S, et al.. The role of miRNAs in viral myocarditis, and its possible implication in induction of mRNA-based COVID-19 vaccines-induced myocarditis. Bull Natl Res Cent. 2022, 46:267. 10.1186\/s42269-022-00955-1","journal-title":"Bull Natl Res Cent"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.24084","article-title":"Comorbidities and symptomatology of SARS-CoV-2 (severe acute respiratory syndrome Coronavirus 2)-related myocarditis and SARS-CoV-2 vaccine-related myocarditis: A review","volume":"14","author":"Cushion S","year":"2022","unstructured":"Cushion S, Arboleda V, Hasanain Y, Demory Beckler M, Hardigan P, Kesselman MM. Comorbidities and symptomatology of SARS-CoV-2 (severe acute respiratory syndrome Coronavirus 2)-related myocarditis and SARS-CoV-2 vaccine-related myocarditis: A review. Cureus. 2022, 14:e24084. 10.7759\/cureus.24084","journal-title":"Cureus"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.3390\/pediatric14040048","article-title":"Myopericarditis in a male adolescent following the second shot of COVID-19 Pfizer m-RNA vaccine: Typical example and analysis of 110 single case reports","volume":"14","author":"Piras A","year":"2022","unstructured":"Piras A, Melis G, Cugusi L, Bassareo PP. Myopericarditis in a male adolescent following the second shot of COVID-19 Pfizer m-RNA vaccine: Typical example and analysis of 110 single case reports. Pediatr Rep. 2022, 14:401-9. 10.3390\/pediatric14040048","journal-title":"Pediatr Rep"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1148\/ryct.210252","article-title":"Cardiac MRI assessment of nonischemic myocardial inflammation: State of the art review and update on myocarditis associated with COVID-19 vaccination","volume":"3","author":"Sanchez Tijmes F","year":"2021","unstructured":"Sanchez Tijmes F, Thavendiranathan P, Udell JA, Seidman MA, Hanneman K. Cardiac MRI assessment of nonischemic myocardial inflammation: State of the art review and update on myocarditis associated with COVID-19 vaccination. Radiol Cardiothorac Imaging. 2021, 3:e210252. 10.1148\/ryct.210252","journal-title":"Radiol Cardiothorac Imaging"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.1016\/j.hrtlng.2023.02.003","article-title":"Cardiovascular complications of COVID-19 vaccines: A review of case-report and case-series studies","volume":"59","author":"Paknahad MH","year":"2023","unstructured":"Paknahad MH, Yancheshmeh FB, Soleimani A. Cardiovascular complications of COVID-19 vaccines: A review of case-report and case-series studies. Heart Lung. 2023, 59:173-80. 10.1016\/j.hrtlng.2023.02.003","journal-title":"Heart Lung"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.1016\/j.repc.2023.01.003","article-title":"Anti-SARS-CoV-2 vaccine-induced myocarditis - real but, in general, rare and mild: A consensus statement from the Studies Committee of the Portuguese Society of Cardiology","volume":"42","author":"Sousa JP","year":"2023","unstructured":"Sousa JP, Roque D, Guerreiro C, Teixeira R. Anti-SARS-CoV-2 vaccine-induced myocarditis - real but, in general, rare and mild: A consensus statement from the Studies Committee of the Portuguese Society of Cardiology. Rev Port Cardiol. 2023, 42:161-7. 10.1016\/j.repc.2023.01.003","journal-title":"Rev Port Cardiol"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.15625","article-title":"A narrative review of vaccine pharmacovigilance during mass vaccination campaigns: Focus on myocarditis and pericarditis after COVID-19 mRNA vaccination","volume":"89","author":"Pich\u00e9-Renaud PP","year":"2023","unstructured":"Pich\u00e9-Renaud PP, Morris SK, Top KA. A narrative review of vaccine pharmacovigilance during mass vaccination campaigns: Focus on myocarditis and pericarditis after COVID-19 mRNA vaccination. Br J Clin Pharmacol. 2023, 89:967-81. 10.1111\/bcp.15625","journal-title":"Br J Clin Pharmacol"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2021-060425","article-title":"Systematic review of spontaneous reports of myocarditis and pericarditis in transplant recipients and immunocompromised patients following COVID-19 mRNA vaccination","volume":"12","author":"Lane S","year":"2022","unstructured":"Lane S, Yeomans A, Shakir S. Systematic review of spontaneous reports of myocarditis and pericarditis in transplant recipients and immunocompromised patients following COVID-19 mRNA vaccination. BMJ Open. 2022, 12:e060425. 10.1136\/bmjopen-2021-060425","journal-title":"BMJ Open"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.1080\/00325481.2022.2161249","article-title":"Current evidence of COVID-19 vaccination-related cardiovascular events","volume":"135","author":"Khiali S","year":"2023","unstructured":"Khiali S, Rezagholizadeh A, Behzad H, Bannazadeh Baghi H, Entezari-Maleki T. Current evidence of COVID-19 vaccination-related cardiovascular events. Postgrad Med. 2023, 135:102-20. 10.1080\/00325481.2022.2161249","journal-title":"Postgrad Med"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines10081316","article-title":"Myocarditis or pericarditis following the COVID-19 vaccination in adolescents: A systematic review","volume":"10","author":"Li M","year":"2022","unstructured":"Li M, Wang X, Feng J, Feng Z, Li W, Ya B. Myocarditis or pericarditis following the COVID-19 vaccination in adolescents: A systematic review. Vaccines (Basel). 2022, 10:1316. 10.3390\/vaccines10081316","journal-title":"Vaccines (Basel)"},{"key":"ref68","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.19240","article-title":"Clinical presentation and outcomes of myocarditis post mRNA vaccination: A meta-analysis and systematic review","volume":"13","author":"Matta A","year":"2021","unstructured":"Matta A, Kunadharaju R, Osman M, et al.. Clinical presentation and outcomes of myocarditis post mRNA vaccination: A meta-analysis and systematic review. Cureus. 2021, 13:e19240. 10.7759\/cureus.19240","journal-title":"Cureus"},{"key":"ref69","unstructured":"In Brief. Myocarditis with the Pfizer\/BioNTech and Moderna COVID-19 Vaccines (online only). (2021). Accessed: January 31, 2024: https:\/\/secure.medicalletter.org\/TML-article-1629i."},{"key":"ref70","doi-asserted-by":"publisher","DOI":"10.1016\/j.amepre.2022.09.002","article-title":"A systematic review and meta-analysis of the association between SARS-CoV-2 vaccination and myocarditis or pericarditis","volume":"64","author":"Gao J","year":"2023","unstructured":"Gao J, Feng L, Li Y, et al.. A systematic review and meta-analysis of the association between SARS-CoV-2 vaccination and myocarditis or pericarditis. Am J Prev Med. 2023, 64:275-84. 10.1016\/j.amepre.2022.09.002","journal-title":"Am J Prev Med"},{"key":"ref71","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.27501","article-title":"Clinical characteristics and prognostic factors of myocarditis associated with the mRNA COVID-19 vaccine","volume":"94","author":"Woo W","year":"2022","unstructured":"Woo W, Kim AY, Yon DK, et al.. Clinical characteristics and prognostic factors of myocarditis associated with the mRNA COVID-19 vaccine. J Med Virol. 2022, 94:1566-80. 10.1002\/jmv.27501","journal-title":"J Med Virol"},{"key":"ref72","doi-asserted-by":"publisher","DOI":"10.1002\/clc.23828","article-title":"Myocarditis after COVID-19 mRNA vaccination: A systematic review of case reports and case series","volume":"45","author":"Park DY","year":"2022","unstructured":"Park DY, An S, Kaur A, Malhotra S, Vij A. Myocarditis after COVID-19 mRNA vaccination: A systematic review of case reports and case series. Clin Cardiol. 2022, 45:691-700. 10.1002\/clc.23828","journal-title":"Clin Cardiol"},{"key":"ref73","doi-asserted-by":"publisher","DOI":"10.1002\/clc.23965","article-title":"Development of myocarditis and pericarditis after COVID-19 vaccination in children and adolescents: A systematic review","volume":"46","author":"Fatima M","year":"2023","unstructured":"Fatima M, Khan MH, Ali MS, et al.. Development of myocarditis and pericarditis after COVID-19 vaccination in children and adolescents: A systematic review. Clin Cardiol. 2023, 46:243-59. 10.1002\/clc.23965","journal-title":"Clin Cardiol"},{"key":"ref74","doi-asserted-by":"publisher","DOI":"10.1002\/iid3.807","article-title":"Adverse events following COVID-19 mRNA vaccines: A systematic review of cardiovascular complication, thrombosis, and thrombocytopenia","volume":"11","author":"Yasmin F","year":"2023","unstructured":"Yasmin F, Najeeb H, Naeem U, et al.. Adverse events following COVID-19 mRNA vaccines: A systematic review of cardiovascular complication, thrombosis, and thrombocytopenia. Immun Inflamm Dis. 2023, 11:e807. 10.1002\/iid3.807","journal-title":"Immun Inflamm Dis"},{"key":"ref75","doi-asserted-by":"publisher","DOI":"10.1016\/j.carrev.2021.08.012","article-title":"Temporal association between the COVID-19 Ad26.COV2.S vaccine and acute myocarditis: A case report and literature review","volume":"38","author":"Sulemankhil I","year":"2022","unstructured":"Sulemankhil I, Abdelrahman M, Negi SI. Temporal association between the COVID-19 Ad26.COV2.S vaccine and acute myocarditis: A case report and literature review. Cardiovasc Revasc Med. 2022, 38:117-23. 10.1016\/j.carrev.2021.08.012","journal-title":"Cardiovasc Revasc Med"},{"key":"ref76","doi-asserted-by":"publisher","DOI":"10.1007\/s40119-023-00309-6","article-title":"Pediatric myocarditis","volume":"12","author":"Williams JL","year":"2023","unstructured":"Williams JL, Jacobs HM, Lee S. Pediatric myocarditis. Cardiol Ther. 2023, 12:243-60. 10.1007\/s40119-023-00309-6","journal-title":"Cardiol Ther"},{"key":"ref77","doi-asserted-by":"publisher","DOI":"10.1016\/j.hfc.2022.08.012","article-title":"Myocarditis following COVID-19 vaccination","volume":"19","author":"Marschner CA","year":"2023","unstructured":"Marschner CA, Shaw KE, Tijmes FS, et al.. Myocarditis following COVID-19 vaccination. Heart Fail Clin. 2023, 19:251-64. 10.1016\/j.hfc.2022.08.012","journal-title":"Heart Fail Clin"},{"key":"ref78","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2021-059223","article-title":"Reports of myocarditis and pericarditis following mRNA COVID-19 vaccination: A systematic review of spontaneously reported data from the UK, Europe and the USA and of the scientific literature","volume":"12","author":"Lane S","year":"2022","unstructured":"Lane S, Yeomans A, Shakir S. Reports of myocarditis and pericarditis following mRNA COVID-19 vaccination: A systematic review of spontaneously reported data from the UK, Europe and the USA and of the scientific literature. BMJ Open. 2022, 12:e059223. 10.1136\/bmjopen-2021-059223","journal-title":"BMJ Open"},{"key":"ref79","doi-asserted-by":"publisher","DOI":"10.4330\/wjc.v14.i6.343","article-title":"COVID-19 vaccination and cardiac dysfunction","volume":"14","author":"Leowattana W","year":"2022","unstructured":"Leowattana W, Leowattana T. COVID-19 vaccination and cardiac dysfunction. World J Cardiol. 2022, 14:343-54. 10.4330\/wjc.v14.i6.343","journal-title":"World J Cardiol"},{"key":"ref80","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.32022","article-title":"COVID-19 vaccination-associated myocarditis: A literature review","volume":"14","author":"Mannan V","year":"2022","unstructured":"Mannan V, Kashyap T, Akram A, et al.. COVID-19 vaccination-associated myocarditis: A literature review. Cureus. 2022, 14:e32022. 10.7759\/cureus.32022","journal-title":"Cureus"},{"key":"ref81","doi-asserted-by":"publisher","DOI":"10.1097\/JCMA.0000000000000774","article-title":"SARS-CoV-2 vaccines in children and adolescents: Can immunization prevent hospitalization?","volume":"85","author":"Liang KH","year":"2022","unstructured":"Liang KH, Hung KF, Wang ML, et al.. SARS-CoV-2 vaccines in children and adolescents: Can immunization prevent hospitalization?. J Chin Med Assoc. 2022, 85:891-5. 10.1097\/JCMA.0000000000000774","journal-title":"J Chin Med Assoc"},{"key":"ref82","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines10122039","article-title":"COVID-19 epidemiology, immunity, and vaccine development in children: A review","volume":"10","author":"Fergie J","year":"2022","unstructured":"Fergie J, Moran MM, Cane A, Pather S, T\u00fcreci \u04e6, Srivastava A. COVID-19 epidemiology, immunity, and vaccine development in children: A review. Vaccines. 2022, 10:2039. 10.3390\/vaccines10122039","journal-title":"Vaccines"},{"key":"ref83","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines10040596","article-title":"Safety of global SARS-CoV-2 vaccines, a meta-analysis","volume":"10","author":"Chen L","year":"2022","unstructured":"Chen L, Cai X, Zhao T, et al.. Safety of global SARS-CoV-2 vaccines, a meta-analysis. Vaccines. 2022, 10:596. 10.3390\/vaccines10040596","journal-title":"Vaccines"},{"key":"ref84","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.27408","article-title":"COVID-19 vaccine-induced myocarditis: A systemic review and literature search","volume":"14","author":"Khan Z","year":"2022","unstructured":"Khan Z, Pabani UK, Gul A, et al.. COVID-19 vaccine-induced myocarditis: A systemic review and literature search. Cureus. 2022, 14:e27408. 10.7759\/cureus.27408","journal-title":"Cureus"},{"key":"ref85","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2200674","article-title":"Safety and efficacy of a third dose of BNT162b2 Covid-19 vaccine","volume":"386","author":"Moreira ED Jr","year":"2022","unstructured":"Moreira ED Jr, Kitchin N, Xu X, et al.. Safety and efficacy of a third dose of BNT162b2 Covid-19 vaccine. N Engl J Med. 2022, 386:1910-21. 10.1056\/NEJMoa2200674","journal-title":"N Engl J Med"},{"key":"ref86","doi-asserted-by":"publisher","DOI":"10.1111\/ejh.13665","article-title":"COVID-19 vaccine-associated immune thrombosis and thrombocytopenia (VITT): Diagnostic and therapeutic recommendations for a new syndrome","volume":"107","author":"Franchini M","year":"2021","unstructured":"Franchini M, Liumbruno GM, Pezzo M. COVID-19 vaccine-associated immune thrombosis and thrombocytopenia (VITT): Diagnostic and therapeutic recommendations for a new syndrome. Eur J Haematol. 2021, 107:173-80. 10.1111\/ejh.13665","journal-title":"Eur J Haematol"},{"key":"ref87","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2021.117607","article-title":"Vaccine-induced immune thrombotic thrombocytopenia and cerebral venous sinus thrombosis post COVID-19 vaccination; a systematic review","volume":"428","author":"Sharifian-Dorche M","year":"2021","unstructured":"Sharifian-Dorche M, Bahmanyar M, Sharifian-Dorche A, Mohammadi P, Nomovi M, Mowla A. Vaccine-induced immune thrombotic thrombocytopenia and cerebral venous sinus thrombosis post COVID-19 vaccination; a systematic review. J Neurol Sci. 2021, 428:117607. 10.1016\/j.jns.2021.117607","journal-title":"J Neurol Sci"},{"key":"ref88","doi-asserted-by":"publisher","DOI":"10.1016\/j.tcm.2022.02.008","article-title":"Thrombosis and thrombocytopenia in COVID-19 and after COVID-19 vaccination","volume":"32","author":"Iba T","year":"2022","unstructured":"Iba T, Levy JH. Thrombosis and thrombocytopenia in COVID-19 and after COVID-19 vaccination. Trends Cardiovasc Med. 2022, 32:249-56. 10.1016\/j.tcm.2022.02.008","journal-title":"Trends Cardiovasc Med"},{"key":"ref89","doi-asserted-by":"publisher","DOI":"10.1016\/j.jstrokecerebrovasdis.2022.106440","article-title":"Stroke associated with COVID-19 vaccines","volume":"31","author":"Kakovan M","year":"2022","unstructured":"Kakovan M, Ghorbani Shirkouhi S, Zarei M, Andalib S. Stroke associated with COVID-19 vaccines. J Stroke Cerebrovasc Dis. 2022, 31:106440. 10.1016\/j.jstrokecerebrovasdis.2022.106440","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"ref90","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.729251","article-title":"COVID-19 vaccine-related thrombosis: A systematic review and exploratory analysis","volume":"12","author":"Bilotta C","year":"2021","unstructured":"Bilotta C, Perrone G, Adelfio V, Spatola GF, Uzzo ML, Argo A, Zerbo S. COVID-19 vaccine-related thrombosis: A systematic review and exploratory analysis. Front Immunol. 2021, 12:729251. 10.3389\/fimmu.2021.729251","journal-title":"Front Immunol"},{"key":"ref91","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(21)00306-9","article-title":"Vaccine-induced immune thrombotic thrombocytopenia","volume":"9","author":"Klok FA","year":"2022","unstructured":"Klok FA, Pai M, Huisman MV, Makris M. Vaccine-induced immune thrombotic thrombocytopenia. Lancet Haematol. 2022, 9:e73-80. 10.1016\/S2352-3026(21)00306-9","journal-title":"Lancet Haematol"},{"key":"ref92","doi-asserted-by":"publisher","DOI":"10.1177\/10760296211021498","article-title":"An update on the pathogenesis of COVID-19 and the reportedly rare thrombotic events following vaccination","volume":"27","author":"Kantarcioglu B","year":"2021","unstructured":"Kantarcioglu B, Iqbal O, Walenga JM, et al.. An update on the pathogenesis of COVID-19 and the reportedly rare thrombotic events following vaccination. Clin Appl Thromb Hemost. 2021, 27:10760296211021498. 10.1177\/10760296211021498","journal-title":"Clin Appl Thromb Hemost"},{"key":"ref93","doi-asserted-by":"publisher","DOI":"10.1177\/10760296211048815","article-title":"COVID-19 vaccine-associated thrombosis with thrombocytopenia syndrome (TTS): A systematic review and post hoc analysis","volume":"27","author":"Hafeez MU","year":"2021","unstructured":"Hafeez MU, Ikram M, Shafiq Z, et al.. COVID-19 vaccine-associated thrombosis with thrombocytopenia syndrome (TTS): A systematic review and post hoc analysis. Clin Appl Thromb Hemost. 2021, 27:10.1177\/10760296211048815","journal-title":"Clin Appl Thromb Hemost"},{"key":"ref94","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2022.120327","article-title":"Acute ischemic stroke and vaccine-induced immune thrombotic thrombocytopenia post COVID-19 vaccination; a systematic review","volume":"439","author":"Kolahchi Z","year":"2022","unstructured":"Kolahchi Z, Khanmirzaei M, Mowla A. Acute ischemic stroke and vaccine-induced immune thrombotic thrombocytopenia post COVID-19 vaccination; a systematic review. J Neurol Sci. 2022, 439:120327. 10.1016\/j.jns.2022.120327","journal-title":"J Neurol Sci"},{"key":"ref95","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.779453","article-title":"Inflammation and platelet activation after COVID-19 vaccines - possible mechanisms behind vaccine-induced immune thrombocytopenia and thrombosis","volume":"12","author":"Ostrowski SR","year":"2021","unstructured":"Ostrowski SR, S\u00f8gaard OS, Tolstrup M, St\u00e6rke NB, Lundgren J, \u00d8stergaard L, Hvas AM. Inflammation and platelet activation after COVID-19 vaccines - possible mechanisms behind vaccine-induced immune thrombocytopenia and thrombosis. Front Immunol. 2021, 12:779453. 10.3389\/fimmu.2021.779453","journal-title":"Front Immunol"},{"key":"ref96","doi-asserted-by":"publisher","DOI":"10.1080\/08830185.2021.1939696","article-title":"Adverse rare events to vaccines for COVID-19: From hypersensitivity reactions to thrombosis and thrombocytopenia","volume":"41","author":"Novak N","year":"2022","unstructured":"Novak N, Tordesillas L, Cabanillas B. Adverse rare events to vaccines for COVID-19: From hypersensitivity reactions to thrombosis and thrombocytopenia. Int Rev Immunol. 2022, 41:438-47. 10.1080\/08830185.2021.1939696","journal-title":"Int Rev Immunol"},{"key":"ref97","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajem.2021.05.054","article-title":"Thrombosis with thrombocytopenia syndrome associated with COVID-19 vaccines","volume":"49","author":"Long B","year":"2021","unstructured":"Long B, Bridwell R, Gottlieb M. Thrombosis with thrombocytopenia syndrome associated with COVID-19 vaccines. Am J Emerg Med. 2021, 49:58-61. 10.1016\/j.ajem.2021.05.054","journal-title":"Am J Emerg Med"},{"key":"ref98","doi-asserted-by":"publisher","DOI":"10.1590\/0004-282X-ANP-2022-S108","article-title":"Cerebral venous thrombosis","volume":"80","author":"Moraes Junior AA","year":"2022","unstructured":"Moraes Junior AA, Conforto AB. Cerebral venous thrombosis. Arq Neuropsiquiatr. 2022, 80:53-9. 10.1590\/0004-282X-ANP-2022-S108","journal-title":"Arq Neuropsiquiatr"},{"key":"ref99","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.122.319954","article-title":"Cerebrovascular complications of COVID-19 and COVID-19 vaccination","volume":"130","author":"De Michele M","year":"2022","unstructured":"De Michele M, Kahan J, Berto I, Schiavo OG, Iacobucci M, Toni D, Merkler AE. Cerebrovascular complications of COVID-19 and COVID-19 vaccination. Circ Res. 2022, 130:1187-203. 10.1161\/CIRCRESAHA.122.319954","journal-title":"Circ Res"},{"key":"ref100","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines9080903","article-title":"COVID-19 pathogenesis: From molecular pathway to vaccine administration","volume":"9","author":"Nappi F","year":"2021","unstructured":"Nappi F, Iervolino A, Avtaar Singh SS. COVID-19 pathogenesis: From molecular pathway to vaccine administration. Biomedicines. 2021, 9:903. 10.3390\/biomedicines9080903","journal-title":"Biomedicines"},{"key":"ref101","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejim.2021.04.019","article-title":"SARS-CoV-2 vaccines: Lights and shadows","volume":"88","author":"Angeli F","year":"2021","unstructured":"Angeli F, Spanevello A, Reboldi G, Visca D, Verdecchia P. SARS-CoV-2 vaccines: Lights and shadows. Eur J Intern Med. 2021, 88:1-8. 10.1016\/j.ejim.2021.04.019","journal-title":"Eur J Intern Med"},{"key":"ref102","doi-asserted-by":"publisher","DOI":"10.2147\/NDT.S374549","article-title":"Acute ischemic stroke in the context of SARS-CoV-2 vaccination: A systematic review","volume":"18","author":"Rahmig J","year":"2022","unstructured":"Rahmig J, Altarsha E, Siepmann T, Barlinn K. Acute ischemic stroke in the context of SARS-CoV-2 vaccination: A systematic review. Neuropsychiatr Dis Treat. 2022, 18:1907-16. 10.2147\/NDT.S374549","journal-title":"Neuropsychiatr Dis Treat"},{"key":"ref103","doi-asserted-by":"publisher","DOI":"10.3390\/biom11071020","article-title":"COVID-19 vaccines and thrombosis\u2014roadblock or dead-end street?","volume":"11","author":"Lundstrom K","year":"2021","unstructured":"Lundstrom K, Barh D, Uhal BD, et al.. COVID-19 vaccines and thrombosis\u2014roadblock or dead-end street?. Biomolecules. 2021, 11:1020. 10.3390\/biom11071020","journal-title":"Biomolecules"},{"key":"ref104","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2022.04.020","article-title":"Thrombotic thrombocytopenic purpura (TTP) after COVID-19 vaccination: A systematic review of reported cases","volume":"214","author":"Saluja P","year":"2022","unstructured":"Saluja P, Gautam N, Yadala S, Venkata AN. Thrombotic thrombocytopenic purpura (TTP) after COVID-19 vaccination: A systematic review of reported cases. Thromb Res. 2022, 214:115-21. 10.1016\/j.thromres.2022.04.020","journal-title":"Thromb Res"},{"key":"ref105","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2021.1949294","article-title":"COVID-19 vaccines and thrombosis with thrombocytopenia syndrome","volume":"20","author":"Lai CC","year":"2021","unstructured":"Lai CC, Ko WC, Chen CJ, Chen PY, Huang YC, Lee PI, Hsueh PR. COVID-19 vaccines and thrombosis with thrombocytopenia syndrome. Expert Rev Vaccines. 2021, 20:1027-35. 10.1080\/14760584.2021.1949294","journal-title":"Expert Rev Vaccines"},{"key":"ref106","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10245876","article-title":"Autopsy findings and causality relationship between death and COVID-19 vaccination: A systematic review","volume":"10","author":"Sessa F","year":"2021","unstructured":"Sessa F, Salerno M, Esposito M, Di Nunno N, Zamboni P, Pomara C. Autopsy findings and causality relationship between death and COVID-19 vaccination: A systematic review. J Clin Med. 2021, 10:5876. 10.3390\/jcm10245876","journal-title":"J Clin Med"},{"key":"ref107","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2021-069445","article-title":"Incidence, risk factors, natural history, and hypothesised mechanisms of myocarditis and pericarditis following covid-19 vaccination: Living evidence syntheses and review","volume":"378","author":"Pillay J","year":"2022","unstructured":"Pillay J, Gaudet L, Wingert A, Bialy L, Mackie AS, Paterson DI, Hartling L. Incidence, risk factors, natural history, and hypothesised mechanisms of myocarditis and pericarditis following covid-19 vaccination: Living evidence syntheses and review. BMJ. 2022, 378:e069445. 10.1136\/bmj-2021-069445","journal-title":"BMJ"},{"key":"ref108","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines10060961","article-title":"COVID-19 vaccines and autoimmune hematologic disorders","volume":"10","author":"Mingot-Castellano ME","year":"2022","unstructured":"Mingot-Castellano ME, Butta N, Canaro M, et al.. COVID-19 vaccines and autoimmune hematologic disorders. Vaccines. 2022, 10:961. 10.3390\/vaccines10060961","journal-title":"Vaccines"},{"key":"ref109","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2021.102662","article-title":"Mechanisms of Immunothrombosis in Vaccine-Induced Thrombotic Thrombocytopenia (VITT) compared to natural SARS-CoV-2 infection","volume":"121","author":"McGonagle D","year":"2021","unstructured":"McGonagle D, De Marco G, Bridgewood C. Mechanisms of Immunothrombosis in Vaccine-Induced Thrombotic Thrombocytopenia (VITT) compared to natural SARS-CoV-2 infection. J Autoimmun. 2021, 121:102662. 10.1016\/j.jaut.2021.102662","journal-title":"J Autoimmun"},{"key":"ref110","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2021.102941","article-title":"Autoimmunity roots of the thrombotic events after COVID-19 vaccination","volume":"20","author":"Elrashdy F","year":"2021","unstructured":"Elrashdy F, Tambuwala MM, Hassan SS, et al.. Autoimmunity roots of the thrombotic events after COVID-19 vaccination. Autoimmun Rev. 2021, 20:102941. 10.1016\/j.autrev.2021.102941","journal-title":"Autoimmun Rev"},{"key":"ref111","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23063338","article-title":"Coagulopathy and fibrinolytic pathophysiology in COVID-19 and SARS-CoV-2 vaccination","volume":"23","author":"Yamada S","year":"2022","unstructured":"Yamada S, Asakura H. Coagulopathy and fibrinolytic pathophysiology in COVID-19 and SARS-CoV-2 vaccination. Int J Mol Sci. 2022, 23:3338. 10.3390\/ijms23063338","journal-title":"Int J Mol Sci"},{"key":"ref112","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejim.2022.08.002","article-title":"Potential mechanisms of vaccine-induced thrombosis","volume":"105","author":"Marietta M","year":"2022","unstructured":"Marietta M, Coluccio V, Luppi M. Potential mechanisms of vaccine-induced thrombosis. Eur J Intern Med. 2022, 105:1-7. 10.1016\/j.ejim.2022.08.002","journal-title":"Eur J Intern Med"},{"key":"ref113","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2022.03.034","article-title":"Thrombosis patterns and clinical outcome of COVID-19 vaccine-induced immune thrombotic thrombocytopenia: A Systematic Review and Meta-Analysis","volume":"119","author":"Kim AY","year":"2022","unstructured":"Kim AY, Woo W, Yon DK, et al.. Thrombosis patterns and clinical outcome of COVID-19 vaccine-induced immune thrombotic thrombocytopenia: A Systematic Review and Meta-Analysis. Int J Infect Dis. 2022, 119:130-9. 10.1016\/j.ijid.2022.03.034","journal-title":"Int J Infect Dis"},{"key":"ref114","doi-asserted-by":"publisher","DOI":"10.1177\/00368504211025927","article-title":"COVID-19 vaccine-induced immune thrombotic thrombocytopenia: A review of the potential mechanisms and proposed management","volume":"104","author":"Alam W","year":"2021","unstructured":"Alam W. COVID-19 vaccine-induced immune thrombotic thrombocytopenia: A review of the potential mechanisms and proposed management. Sci Prog. 2021, 104:10.1177\/00368504211025927","journal-title":"Sci Prog"},{"key":"ref115","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.37275","article-title":"Thrombotic and thromboembolic complications after vaccination against COVID-19: A systematic review","volume":"15","author":"Favas TT","year":"2023","unstructured":"Favas TT, Lall N, Joshi D, et al.. Thrombotic and thromboembolic complications after vaccination against COVID-19: A systematic review. Cureus. 2023, 15:e37275. 10.7759\/cureus.37275","journal-title":"Cureus"},{"key":"ref116","doi-asserted-by":"publisher","DOI":"10.1177\/21501319221074450","article-title":"Cerebral venous sinus thrombosis following COVID-19 vaccination: A systematic review","volume":"13","author":"Jaiswal V","year":"2022","unstructured":"Jaiswal V, Nepal G, Dijamco P, et al.. Cerebral venous sinus thrombosis following COVID-19 vaccination: A systematic review. J Prim Care Community Health. 2022, 13:10.1177\/21501319221074450","journal-title":"J Prim Care Community Health"},{"key":"ref117","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2021.05.018","article-title":"Spontaneous HIT syndrome: Knee replacement, infection, and parallels with vaccine-induced immune thrombotic thrombocytopenia","volume":"204","author":"Warkentin TE","year":"2021","unstructured":"Warkentin TE, Greinacher A. Spontaneous HIT syndrome: Knee replacement, infection, and parallels with vaccine-induced immune thrombotic thrombocytopenia. Thromb Res. 2021, 204:40-51. 10.1016\/j.thromres.2021.05.018","journal-title":"Thromb Res"},{"key":"ref118","doi-asserted-by":"publisher","DOI":"10.1016\/j.avsg.2022.05.001","article-title":"Thromboembolism after COVID-19 vaccination: A systematic review of such events in 286 patients","volume":"84","author":"Mani A","year":"2022","unstructured":"Mani A, Ojha V. Thromboembolism after COVID-19 vaccination: A systematic review of such events in 286 patients. Ann Vasc Surg. 2022, 84:12-20.e1. 10.1016\/j.avsg.2022.05.001","journal-title":"Ann Vasc Surg"},{"key":"ref119","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2022.02.009","article-title":"Vaccine-induced immune thrombotic thrombocytopenia and patients with cancer","volume":"213","author":"Connors JM","year":"2022","unstructured":"Connors JM, Iba T. Vaccine-induced immune thrombotic thrombocytopenia and patients with cancer. Thromb Res. 2022, 213:S77-83. 10.1016\/j.thromres.2022.02.009","journal-title":"Thromb Res"},{"key":"ref120","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2022.1040196","article-title":"Vaccine-induced immune thrombotic thrombocytopenia: Updates in pathobiology and diagnosis","volume":"9","author":"Jevtic SD","year":"2022","unstructured":"Jevtic SD, Arnold DM, Modi D, Ivetic N, Bissola AL, Nazy I. Vaccine-induced immune thrombotic thrombocytopenia: Updates in pathobiology and diagnosis. Front Cardiovasc Med. 2022, 9:1040196. 10.3389\/fcvm.2022.1040196","journal-title":"Front Cardiovasc Med"},{"key":"ref121","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2022.967926","article-title":"Thrombotic events with or without thrombocytopenia in recipients of adenovirus-based COVID-19 vaccines","volume":"9","author":"Cari L","year":"2022","unstructured":"Cari L, Naghavi Alhosseini M, Bergamo A, Pacor S, Pierno S, Sava G, Nocentini G. Thrombotic events with or without thrombocytopenia in recipients of adenovirus-based COVID-19 vaccines. Front Cardiovasc Med. 2022, 9:967926. 10.3389\/fcvm.2022.967926","journal-title":"Front Cardiovasc Med"},{"key":"ref122","doi-asserted-by":"publisher","DOI":"10.3390\/hematolrep14040050","article-title":"COVID-19 adenoviral vaccine-induced immune thrombotic thrombocytopenia (VITT), COVID-19-related thrombosis, and the thrombotic thrombocytopenic syndromes","volume":"14","author":"Allas GD","year":"2022","unstructured":"Allas GD, Arizala JD, Manalo RV. COVID-19 adenoviral vaccine-induced immune thrombotic thrombocytopenia (VITT), COVID-19-related thrombosis, and the thrombotic thrombocytopenic syndromes. Hematol Rep. 2022, 14:358-72. 10.3390\/hematolrep14040050","journal-title":"Hematol Rep"},{"key":"ref123","doi-asserted-by":"publisher","DOI":"10.1177\/10760296211040110","article-title":"Concern about the adverse effects of thrombocytopenia and thrombosis after adenovirus-vectored COVID-19 vaccination","volume":"27","author":"Haimei MA","year":"2021","unstructured":"Haimei MA. Concern about the adverse effects of thrombocytopenia and thrombosis after adenovirus-vectored COVID-19 vaccination. Clin Appl Thromb Hemost. 2021, 27:10.1177\/10760296211040110","journal-title":"Clin Appl Thromb Hemost"},{"key":"ref124","doi-asserted-by":"publisher","DOI":"10.1007\/s12185-021-03190-y","article-title":"Thrombotic thrombocytopenic purpura: A new menace after COVID bnt162b2 vaccine","volume":"114","author":"Waqar SH","year":"2021","unstructured":"Waqar SH, Khan AA, Memon S. Thrombotic thrombocytopenic purpura: A new menace after COVID bnt162b2 vaccine. Int J Hematol. 2021, 114:626-9. 10.1007\/s12185-021-03190-y","journal-title":"Int J Hematol"},{"key":"ref125","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-022-11101-2","article-title":"Cerebral venous sinus thrombosis in the setting of COVID-19 vaccination: A systematic review and meta-analysis","volume":"269","author":"Palaiodimou L","year":"2022","unstructured":"Palaiodimou L, Stefanou MI, de Sousa DA, et al.. Cerebral venous sinus thrombosis in the setting of COVID-19 vaccination: A systematic review and meta-analysis. J Neurol. 2022, 269:3413-9. 10.1007\/s00415-022-11101-2","journal-title":"J Neurol"},{"key":"ref126","doi-asserted-by":"publisher","DOI":"10.1016\/j.sjbs.2021.09.065","article-title":"Thrombosis formation after COVID-19 vaccination Immunological Aspects: Review article","volume":"29","author":"Waggiallah HA","year":"2022","unstructured":"Waggiallah HA. Thrombosis formation after COVID-19 vaccination Immunological Aspects: Review article. Saudi J Biol Sci. 2022, 29:1073-8. 10.1016\/j.sjbs.2021.09.065","journal-title":"Saudi J Biol Sci"},{"key":"ref127","doi-asserted-by":"publisher","DOI":"10.1093\/labmed\/lmac016","article-title":"Acquired thrombotic thrombocytopenic purpura after BNT162b2 COVID-19 vaccine: Case report and literature review","volume":"53","author":"Hammami E","year":"2022","unstructured":"Hammami E, Lamarque M, Aujoulat O, Debliquis A, Dr\u00e9nou B, Harzallah I. Acquired thrombotic thrombocytopenic purpura after BNT162b2 COVID-19 vaccine: Case report and literature review. Lab Med. 2022, 53:e145-8. 10.1093\/labmed\/lmac016","journal-title":"Lab Med"},{"key":"ref128","doi-asserted-by":"publisher","DOI":"10.1177\/10760296211068487","article-title":"Thrombosis with thrombocytopenia syndrome after administration of AZD1222 or Ad26.COV2.S vaccine for COVID- 19: A systematic review","volume":"27","author":"Waqar U","year":"2021","unstructured":"Waqar U, Ahmed S, Gardezi SM, et al.. Thrombosis with thrombocytopenia syndrome after administration of AZD1222 or Ad26.COV2.S vaccine for COVID- 19: A systematic review. Clin Appl Thromb Hemost. 2021, 27:10.1177\/10760296211068487","journal-title":"Clin Appl Thromb Hemost"},{"key":"ref129","doi-asserted-by":"publisher","DOI":"10.2459\/JCM.0000000000001232","article-title":"Concerning the unexpected prothrombotic state following some coronavirus disease 2019 vaccines","volume":"23","author":"Calcaterra G","year":"2022","unstructured":"Calcaterra G, Bassareo PP, Barilla' F, Romeo F, Mehta JL. Concerning the unexpected prothrombotic state following some coronavirus disease 2019 vaccines. J Cardiovasc Med. 2022, 23:71-4. 10.2459\/JCM.0000000000001232","journal-title":"J Cardiovasc Med"},{"key":"ref130","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000200996","article-title":"Acute arterial ischemic stroke following COVID-19 vaccination: A systematic review and meta-analysis","volume":"99","author":"Stefanou MI","year":"2022","unstructured":"Stefanou MI, Palaiodimou L, Aguiar de Sousa D, et al.. Acute arterial ischemic stroke following COVID-19 vaccination: A systematic review and meta-analysis. Neurology. 2022, 99:e1465-74. 10.1212\/WNL.0000000000200996","journal-title":"Neurology"},{"key":"ref131","doi-asserted-by":"publisher","DOI":"10.1007\/s12010-022-04181-3","article-title":"SARS-CoV-2 vaccines: Types, working principle, and its impact on thrombosis and gastrointestinal disorders","volume":"195","author":"Khare S","year":"2023","unstructured":"Khare S, Niharika, Singh A, Hussain I, Singh NB, Singh S. SARS-CoV-2 vaccines: Types, working principle, and its impact on thrombosis and gastrointestinal disorders. Appl Biochem Biotechnol. 2023, 195:1541-73. 10.1007\/s12010-022-04181-3","journal-title":"Appl Biochem Biotechnol"},{"key":"ref132","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000012896","article-title":"Cerebral venous sinus thrombosis and thrombotic events after vector-based COVID-19 vaccines: A systematic review and meta-analysis","volume":"97","author":"Palaiodimou L","year":"2021","unstructured":"Palaiodimou L, Stefanou MI, Katsanos AH, et al.. Cerebral venous sinus thrombosis and thrombotic events after vector-based COVID-19 vaccines: A systematic review and meta-analysis. Neurology. 2021, 97:e2136-47. 10.1212\/WNL.0000000000012896","journal-title":"Neurology"},{"key":"ref133","doi-asserted-by":"publisher","DOI":"10.7861\/clinmed.2022-0006","article-title":"The aetiopathogenesis of vaccine-induced immune thrombotic thrombocytopenia","volume":"22","author":"Toh CH","year":"2022","unstructured":"Toh CH, Wang G, Parker AL. The aetiopathogenesis of vaccine-induced immune thrombotic thrombocytopenia. Clin Med. 2022, 22:140-4. 10.7861\/clinmed.2022-0006","journal-title":"Clin Med"},{"key":"ref134","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2022-071594","article-title":"Comparative risk of thrombosis with thrombocytopenia syndrome or thromboembolic events associated with different covid-19 vaccines: international network cohort study from five European countries and the US","volume":"379","author":"Li X","year":"2022","unstructured":"Li X, Burn E, Duarte-Salles T, et al.. Comparative risk of thrombosis with thrombocytopenia syndrome or thromboembolic events associated with different covid-19 vaccines: international network cohort study from five European countries and the US. BMJ. 2022, 379:e071594. 10.1136\/bmj-2022-071594","journal-title":"BMJ"},{"key":"ref135","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/7702863","article-title":"Possible risk of thrombotic events following Oxford-AstraZeneca COVID-19 vaccination in women receiving estrogen","volume":"2021","author":"Soltani Hekmat A","year":"2021","unstructured":"Soltani Hekmat A, Javanmardi K. Possible risk of thrombotic events following Oxford-AstraZeneca COVID-19 vaccination in women receiving estrogen. Biomed Res Int. 2021, 2021:7702863. 10.1155\/2021\/7702863","journal-title":"Biomed Res Int"},{"key":"ref136","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.121.036824","article-title":"Cerebral venous thrombosis in patients with heparin-induced thrombocytopenia a systematic review","volume":"53","author":"Aguiar de Sousa D","year":"2022","unstructured":"Aguiar de Sousa D, Romoli M, S\u00e1nchez Van Kammen M, et al.. Cerebral venous thrombosis in patients with heparin-induced thrombocytopenia a systematic review. Stroke. 2022, 53:1892-903. 10.1161\/STROKEAHA.121.036824","journal-title":"Stroke"},{"key":"ref137","doi-asserted-by":"publisher","DOI":"10.1177\/02683555211068948","article-title":"Vaccine-induced immune thrombotic thrombocytopenia with atypical vein thrombosis: Implications for clinical practice","volume":"37","author":"Zamboni P","year":"2022","unstructured":"Zamboni P, Scerrati A, Sessa F, Pomara C, Mannucci PM. Vaccine-induced immune thrombotic thrombocytopenia with atypical vein thrombosis: Implications for clinical practice. Phlebology. 2022, 37:180-7. 10.1177\/02683555211068948","journal-title":"Phlebology"},{"key":"ref138","doi-asserted-by":"publisher","DOI":"10.1055\/a-1481-3039","article-title":"Vaccine-induced immune thrombotic thrombocytopenia (VITT): Targeting pathomechanisms with bruton tyrosine kinase inhibitors","volume":"121","author":"von Hundelshausen P","year":"2021","unstructured":"von Hundelshausen P, Lorenz R, Siess W, Weber C. Vaccine-induced immune thrombotic thrombocytopenia (VITT): Targeting pathomechanisms with bruton tyrosine kinase inhibitors. Thromb Haemost. 2021, 121:1395-9. 10.1055\/a-1481-3039","journal-title":"Thromb Haemost"},{"key":"ref139","doi-asserted-by":"publisher","DOI":"10.1093\/immadv\/ltab019","article-title":"The clinical correlates of vaccine-induced immune thrombotic thrombocytopenia after immunisation with adenovirus vector-based SARS-CoV-2 vaccines","volume":"1","author":"Gaunt ER","year":"2021","unstructured":"Gaunt ER, Mabbott NA. The clinical correlates of vaccine-induced immune thrombotic thrombocytopenia after immunisation with adenovirus vector-based SARS-CoV-2 vaccines. Immunother Adv. 2021, 1:ltab019. 10.1093\/immadv\/ltab019","journal-title":"Immunother Adv"},{"key":"ref140","doi-asserted-by":"publisher","DOI":"10.1016\/j.jiph.2022.04.008","article-title":"Vaccine-induced immune thrombotic thrombocytopenia after ChAdOx1 nCoV-19 vaccine in an older patient: Minireview and a case report","volume":"15","author":"Luciano PQ","year":"2022","unstructured":"Luciano PQ, Binatti R, Sodr\u00e9 AR, Zajac SR, Marson FA, Ortega MM. Vaccine-induced immune thrombotic thrombocytopenia after ChAdOx1 nCoV-19 vaccine in an older patient: Minireview and a case report. J Infect Public Health. 2022, 15:638-42. 10.1016\/j.jiph.2022.04.008","journal-title":"J Infect Public Health"},{"key":"ref141","doi-asserted-by":"publisher","DOI":"10.1212\/CON.0000000000001211","article-title":"Diagnosis and treatment of cerebral venous thrombosis","volume":"29","author":"Liberman AL","year":"2023","unstructured":"Liberman AL. Diagnosis and treatment of cerebral venous thrombosis. Continuum (Minneap Minn). 2023, 29:519-39. 10.1212\/CON.0000000000001211","journal-title":"Continuum (Minneap Minn)"},{"key":"ref142","doi-asserted-by":"publisher","DOI":"10.5692\/clinicalneurol.cn-001646","article-title":"Cerebral vein\/venous sinus thrombosis with thrombocytopenia syndrome after COVID-19 vaccination. (Article in Japanese)","volume":"61","author":"Kawano H","year":"2021","unstructured":"Kawano H, Hashimoto Y, Hirano T. Cerebral vein\/venous sinus thrombosis with thrombocytopenia syndrome after COVID-19 vaccination. (Article in Japanese). Rinsho Shinkeigaku. 2021, 61:594-601. 10.5692\/clinicalneurol.cn-001646","journal-title":"Rinsho Shinkeigaku"},{"key":"ref143","doi-asserted-by":"publisher","DOI":"10.1007\/s11239-021-02626-w","article-title":"A systematic review of vaccine-induced thrombotic thrombocytopenia in individuals who received COVID-19 adenoviral-vector-based vaccines","volume":"53","author":"Elberry MH","year":"2022","unstructured":"Elberry MH, Abdelgawad HA, Hamdallah A, Abdella WS, Ahmed AS, Ghaith HS, Negida A. A systematic review of vaccine-induced thrombotic thrombocytopenia in individuals who received COVID-19 adenoviral-vector-based vaccines. J Thromb Thrombolysis. 2022, 53:798-823. 10.1007\/s11239-021-02626-w","journal-title":"J Thromb Thrombolysis"},{"key":"ref144","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.794599","article-title":"Portal vein thrombosis might develop by COVID-19 infection or vaccination: A systematic review of case-report studies","volume":"8","author":"Kheyrandish S","year":"2021","unstructured":"Kheyrandish S, Rastgar A, Arab-Zozani M, Sarab GA. Portal vein thrombosis might develop by COVID-19 infection or vaccination: A systematic review of case-report studies. Front Med (Lausanne). 2021, 8:794599. 10.3389\/fmed.2021.794599","journal-title":"Front Med (Lausanne)"},{"key":"ref145","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.26480","article-title":"Immune thrombocytopenia in previously healthy individuals following SARS-CoV-2 vaccination (COVID-19 Immunization): A descriptive research of 70 instances with a focus on biomarkers, predictive outcomes, and consequences","volume":"14","author":"Sharma K","year":"2022","unstructured":"Sharma K, Patel S, Patel Z, et al.. Immune thrombocytopenia in previously healthy individuals following SARS-CoV-2 vaccination (COVID-19 Immunization): A descriptive research of 70 instances with a focus on biomarkers, predictive outcomes, and consequences. Cureus. 2022, 14:e26480. 10.7759\/cureus.26480","journal-title":"Cureus"},{"key":"ref146","doi-asserted-by":"publisher","DOI":"10.1097\/MBC.0000000000001113","article-title":"Outcomes of patients with thromboembolic events following coronavirus disease 2019 AstraZeneca vaccination: A systematic review and meta-analysis","volume":"33","author":"Matar RH","year":"2022","unstructured":"Matar RH, Than CA, Nakanishi H, et al.. Outcomes of patients with thromboembolic events following coronavirus disease 2019 AstraZeneca vaccination: A systematic review and meta-analysis. Blood Coagul Fibrinolysis. 2022, 33:90-112. 10.1097\/MBC.0000000000001113","journal-title":"Blood Coagul Fibrinolysis"},{"key":"ref147","doi-asserted-by":"publisher","DOI":"10.1186\/s12959-021-00318-2","article-title":"Platelet factor 4 polyanion immune complexes: Heparin induced thrombocytopenia and vaccine-induced immune thrombotic thrombocytopenia","volume":"19","author":"Datta P","year":"2021","unstructured":"Datta P, Zhang F, Dordick JS, Linhardt RJ. Platelet factor 4 polyanion immune complexes: Heparin induced thrombocytopenia and vaccine-induced immune thrombotic thrombocytopenia. Thromb J. 2021, 19:66. 10.1186\/s12959-021-00318-2","journal-title":"Thromb J"},{"key":"ref148","doi-asserted-by":"publisher","DOI":"10.26355\/eurrev_202108_26464","article-title":"Vaccine-induced severe thrombotic thrombocytopenia following COVID-19 vaccination: A report of an autoptic case and review of the literature","volume":"25","author":"Fanni D","year":"2021","unstructured":"Fanni D, Saba L, Demontis R, et al.. Vaccine-induced severe thrombotic thrombocytopenia following COVID-19 vaccination: A report of an autoptic case and review of the literature. Eur Rev Med Pharmacol Sci. 2021, 25:5063-9. 10.26355\/eurrev_202108_26464","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"ref149","doi-asserted-by":"publisher","DOI":"10.1007\/s11239-022-02732-3","article-title":"Incidence and outcomes of splanchnic vein thrombosis after diagnosis of COVID-19 or COVID-19 vaccination: A systematic review and meta-analysis","volume":"55","author":"Zheng X","year":"2023","unstructured":"Zheng X, Gao F, Wang L, Meng Y, Ageno W, Qi X. Incidence and outcomes of splanchnic vein thrombosis after diagnosis of COVID-19 or COVID-19 vaccination: A systematic review and meta-analysis. J Thromb Thrombolysis. 2023, 55:18-31. 10.1007\/s11239-022-02732-3","journal-title":"J Thromb Thrombolysis"},{"key":"ref150","doi-asserted-by":"publisher","DOI":"10.1159\/000524290","article-title":"Ischemic stroke and vaccine-induced immune thrombotic thrombocytopenia following COVID-19 vaccine: A case report with systematic review of the literature","volume":"51","author":"Cascio Rizzo A","year":"2022","unstructured":"Cascio Rizzo A, Giussani G, Agostoni EC. Ischemic stroke and vaccine-induced immune thrombotic thrombocytopenia following COVID-19 vaccine: A case report with systematic review of the literature. Cerebrovasc Dis. 2022, 51:722-34. 10.1159\/000524290","journal-title":"Cerebrovasc Dis"},{"key":"ref151","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.708665","article-title":"Targeting SARS-CoV-2-platelet interactions in COVID-19 and vaccine-related thrombosis","volume":"12","author":"Cox D","year":"2021","unstructured":"Cox D. Targeting SARS-CoV-2-platelet interactions in COVID-19 and vaccine-related thrombosis. Front Pharmacol. 2021, 12:708665. 10.3389\/fphar.2021.708665","journal-title":"Front Pharmacol"},{"key":"ref152","doi-asserted-by":"publisher","DOI":"10.1186\/s41983-021-00431-z","article-title":"Post-SARS-CoV-2 vaccination venous sinus thrombosis: A literature review of 308 cases","volume":"57","author":"Finsterer J","year":"2021","unstructured":"Finsterer J, Zarrouk S. Post-SARS-CoV-2 vaccination venous sinus thrombosis: A literature review of 308 cases. Egypt J Neurol Psychiatr Neurosurg. 2021, 57:179. 10.1186\/s41983-021-00431-z","journal-title":"Egypt J Neurol Psychiatr Neurosurg"},{"key":"ref153","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2021012152","article-title":"Vaccine-induced immune thrombotic thrombocytopenia: What we know and do not know","volume":"138","author":"Arepally GM","year":"2021","unstructured":"Arepally GM, Ortel TL. Vaccine-induced immune thrombotic thrombocytopenia: What we know and do not know. Blood. 2021, 138:293-8. 10.1182\/blood.2021012152","journal-title":"Blood"},{"key":"ref154","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2021.3444","article-title":"Clinical characteristics and pharmacological management of COVID-19 vaccine-induced immune thrombotic thrombocytopenia with cerebral venous sinus thrombosis: A review","volume":"6","author":"Rizk JG","year":"2021","unstructured":"Rizk JG, Gupta A, Sardar P, Henry BM, Lewin JC, Lippi G, Lavie CJ. Clinical characteristics and pharmacological management of COVID-19 vaccine-induced immune thrombotic thrombocytopenia with cerebral venous sinus thrombosis: A review. JAMA Cardiol. 2021, 6:1451-60. 10.1001\/jamacardio.2021.3444","journal-title":"JAMA Cardiol"},{"key":"ref155","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10061246","article-title":"Thrombotic complications after COVID-19 vaccination: Diagnosis and treatment options","volume":"10","author":"Guetl K","year":"2022","unstructured":"Guetl K, Raggam RB, Gary T. Thrombotic complications after COVID-19 vaccination: Diagnosis and treatment options. Biomedicines. 2022, 10:1246. 10.3390\/biomedicines10061246","journal-title":"Biomedicines"},{"key":"ref156","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2022.840929","article-title":"Cardiovascular complications of COVID-19 vaccines","volume":"9","author":"Liu R","year":"2022","unstructured":"Liu R, Pan J, Zhang C, Sun X. Cardiovascular complications of COVID-19 vaccines. Front Cardiovasc Med. 2022, 9:840929. 10.3389\/fcvm.2022.840929","journal-title":"Front Cardiovasc Med"},{"key":"ref157","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1004024","article-title":"Safety evaluation of the single-dose Ad26.COV2.S vaccine among healthcare workers in the Sisonke study in South Africa: A phase 3b implementation trial","volume":"19","author":"Takuva S","year":"2022","unstructured":"Takuva S, Takalani A, Seocharan I, et al.. Safety evaluation of the single-dose Ad26.COV2.S vaccine among healthcare workers in the Sisonke study in South Africa: A phase 3b implementation trial. PLoS Med. 2022, 19:e1004024. 10.1371\/journal.pmed.1004024","journal-title":"PLoS Med"},{"key":"ref158","doi-asserted-by":"publisher","DOI":"10.1080\/07391102.2021.1927847","article-title":"COVID-19 vector-based vaccine causing thrombosis","volume":"40","author":"Hendaus MA","year":"2022","unstructured":"Hendaus MA, Jomha FA. COVID-19 vector-based vaccine causing thrombosis. J Biomol Struct Dyn. 2022, 40:9568-70. 10.1080\/07391102.2021.1927847","journal-title":"J Biomol Struct Dyn"},{"key":"ref159","doi-asserted-by":"publisher","DOI":"10.1111\/ejh.13855","article-title":"COVID-19: Vaccine-induced immune thrombotic thrombocytopenia","volume":"109","author":"Danish FI","year":"2022","unstructured":"Danish FI, Rabani AE, Subhani FE, Yasmin S, Koul SS. COVID-19: Vaccine-induced immune thrombotic thrombocytopenia. Eur J Haematol. 2022, 109:619-32. 10.1111\/ejh.13855","journal-title":"Eur J Haematol"},{"key":"ref160","doi-asserted-by":"publisher","DOI":"10.1186\/s12959-021-00340-4","article-title":"Thromboembolic and hemorrhagic risks after vaccination against SARS-CoV-2: A systematic review and meta-analysis of randomized controlled trials","volume":"19","author":"Uaprasert N","year":"2021","unstructured":"Uaprasert N, Panrong K, Rojnuckarin P, Chiasakul T. Thromboembolic and hemorrhagic risks after vaccination against SARS-CoV-2: A systematic review and meta-analysis of randomized controlled trials. Thromb J. 2021, 19:86. 10.1186\/s12959-021-00340-4","journal-title":"Thromb J"},{"key":"ref161","doi-asserted-by":"publisher","DOI":"10.5588\/ijtld.21.0298","article-title":"Thrombotic events and COVID-19 vaccines","volume":"25","author":"Brazete C","year":"2021","unstructured":"Brazete C, Aguiar A, Furtado I, Duarte R. Thrombotic events and COVID-19 vaccines. Int J Tuberc Lung Dis. 2021, 25:701-7. 10.5588\/ijtld.21.0298","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref162","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2022.e11385","article-title":"Myocardial infarction following COVID-19 vaccine administration; a systematic review","volume":"8","author":"Baqi DH","year":"2022","unstructured":"Baqi DH, Kakamad FH, Mahmood ZH, et al.. Myocardial infarction following COVID-19 vaccine administration; a systematic review. Heliyon. 2022, 8:e11385. 10.1016\/j.heliyon.2022.e11385","journal-title":"Heliyon"},{"key":"ref163","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2021.12.010","article-title":"Rationale and design of a study to assess the safety and efficacy of rNAPc2 in COVID-19: The Phase 2b ASPEN-COVID-19 trial","volume":"246","author":"Hess CN","year":"2022","unstructured":"Hess CN, Capell WH, Bristow MR, et al.. Rationale and design of a study to assess the safety and efficacy of rNAPc2 in COVID-19: The Phase 2b ASPEN-COVID-19 trial. Am Heart J. 2022, 246:136-43. 10.1016\/j.ahj.2021.12.010","journal-title":"Am Heart J"},{"key":"ref164","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000207062","article-title":"Reader response: Acute arterial ischemic stroke following COVID-19 vaccination: A systematic review and meta-analysis","volume":"100","author":"Du L","year":"2023","unstructured":"Du L, Li Z, Zhao Y. Reader response: Acute arterial ischemic stroke following COVID-19 vaccination: A systematic review and meta-analysis. Neurology. 2023, 100:446-7. 10.1212\/WNL.0000000000207062","journal-title":"Neurology"},{"key":"ref165","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcha.2022.101108","article-title":"Global reports of takotsubo (stress) cardiomyopathy following COVID-19 vaccination: A systematic review and meta-analysis","volume":"43","author":"Ahmed SK","year":"2022","unstructured":"Ahmed SK, Mohamed MG, Essa RA, Dabou EA, Abdulqadir SO, Omar RM. Global reports of takotsubo (stress) cardiomyopathy following COVID-19 vaccination: A systematic review and meta-analysis. Int J Cardiol Heart Vasc. 2022, 43:101108. 10.1016\/j.ijcha.2022.101108","journal-title":"Int J Cardiol Heart Vasc"},{"key":"ref166","doi-asserted-by":"publisher","DOI":"10.3390\/jcdd9050150","article-title":"Blood pressure increase following COVID-19 vaccination: A systematic overview and meta-analysis","volume":"9","author":"Angeli F","year":"2022","unstructured":"Angeli F, Reboldi G, Trapasso M, Santilli G, Zappa M, Verdecchia P. Blood pressure increase following COVID-19 vaccination: A systematic overview and meta-analysis. J Cardiovasc Dev Dis. 2022, 9:150. 10.3390\/jcdd9050150","journal-title":"J Cardiovasc Dev Dis"},{"key":"ref167","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2021.36.e312","article-title":"Multisystem inflammatory syndrome in an adult after COVID-19 vaccination: A case report and literature review","volume":"36","author":"Park JW","year":"2021","unstructured":"Park JW, Yu SN, Chang SH, Ahn YH, Jeon MH. Multisystem inflammatory syndrome in an adult after COVID-19 vaccination: A case report and literature review. J Korean Med Sci. 2021, 36:e312. 10.3346\/jkms.2021.36.e312","journal-title":"J Korean Med Sci"},{"key":"ref168","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2023.103341","article-title":"Increased incidence of giant cell arteritis and associated stroke during the COVID-19 pandemic in Spain: A nation-wide population study","volume":"22","author":"Moreno-Torres V","year":"2023","unstructured":"Moreno-Torres V, Soriano V, Calder\u00f3n-Parra J, et al.. Increased incidence of giant cell arteritis and associated stroke during the COVID-19 pandemic in Spain: A nation-wide population study. Autoimmun Rev. 2023, 22:103341. 10.1016\/j.autrev.2023.103341","journal-title":"Autoimmun Rev"},{"key":"ref169","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2010.10.067","article-title":"Adverse events associated with pandemic influenza vaccines: Comparison of the results of a follow-up study with those coming from spontaneous reporting","volume":"29","author":"Carvajal A","year":"2011","unstructured":"Carvajal A, Ortega PG, S\u00e1inz M, et al.. Adverse events associated with pandemic influenza vaccines: Comparison of the results of a follow-up study with those coming from spontaneous reporting. Vaccine. 2011, 29:519-22. 10.1016\/j.vaccine.2010.10.067","journal-title":"Vaccine"},{"key":"ref170","doi-asserted-by":"publisher","DOI":"10.1097\/00006454-200012000-00002","article-title":"Serious adverse events after measles-mumps-rubella vaccination during a fourteen-year prospective follow-up","volume":"19","author":"Patja A","year":"2000","unstructured":"Patja A, Davidkin I, Kurki T, Kallio MJ, Valle M, Peltola H. Serious adverse events after measles-mumps-rubella vaccination during a fourteen-year prospective follow-up. Pediatr Infect Dis J. 2000, 19:1127-34. 10.1097\/00006454-200012000-00002","journal-title":"Pediatr Infect Dis J"},{"key":"ref171","doi-asserted-by":"publisher","DOI":"10.1016\/j.jadohealth.2017.08.004","article-title":"Reports of postural orthostatic tachycardia syndrome after human papillomavirus vaccination in the vaccine adverse event reporting system","volume":"61","author":"Arana J","year":"2017","unstructured":"Arana J, Mba-Jonas A, Jankosky C, Lewis P, Moro PL, Shimabukuro TT, Cano M. Reports of postural orthostatic tachycardia syndrome after human papillomavirus vaccination in the vaccine adverse event reporting system. J Adolesc Health. 2017, 61:577-82. 10.1016\/j.jadohealth.2017.08.004","journal-title":"J Adolesc Health"},{"key":"ref172","doi-asserted-by":"publisher","DOI":"10.1016\/j.dsx.2020.03.013","article-title":"Cardiovascular disease and COVID-19","volume":"14","author":"Bansal M","year":"2020","unstructured":"Bansal M. Cardiovascular disease and COVID-19. Diabetes Metab Syndr. 2020, 14:247-50. 10.1016\/j.dsx.2020.03.013","journal-title":"Diabetes Metab Syndr"},{"key":"ref173","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.120.050434","article-title":"Myocardial injury in adults hospitalized with COVID-19","volume":"142","author":"Smilowitz NR","year":"2020","unstructured":"Smilowitz NR, Jethani N, Chen J, et al.. Myocardial injury in adults hospitalized with COVID-19. Circulation. 2020, 142:2393-5. 10.1161\/CIRCULATIONAHA.120.050434","journal-title":"Circulation"},{"key":"ref174","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.120.046941","article-title":"COVID-19 and cardiovascular disease","volume":"141","author":"Clerkin KJ","year":"2020","unstructured":"Clerkin KJ, Fried JA, Raikhelkar J, et al.. COVID-19 and cardiovascular disease. Circulation. 2020, 141:1648-55. 10.1161\/CIRCULATIONAHA.120.046941","journal-title":"Circulation"},{"key":"ref175","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2023.2230828","article-title":"Risk of all-cause and cardiac-related mortality after vaccination against COVID-19: A meta-analysis of self-controlled case series studies","volume":"19","author":"Marchand G","year":"2023","unstructured":"Marchand G, Masoud AT, Medi S. Risk of all-cause and cardiac-related mortality after vaccination against COVID-19: A meta-analysis of self-controlled case series studies. Hum Vaccin Immunother. 2023, 19:2230828. 10.1080\/21645515.2023.2230828","journal-title":"Hum Vaccin Immunother"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/332797-cardiovascular-sequelae-of-the-covid-19-vaccines","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T00:45:14Z","timestamp":1744332314000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/332797-cardiovascular-sequelae-of-the-covid-19-vaccines"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,10]]},"references-count":175,"URL":"https:\/\/doi.org\/10.7759\/cureus.82041","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4,10]]}}}